At JRG Partners we sit on the other side of these searches every day, so this reflects what we actually see working for candidates. Entering pharmaceutical leadership from another industry is possible but narrower than most candidates hope, because the sector’s regulatory and scientific dimensions create genuine barriers in some functions and almost none in others. The realistic approach is to identify where your existing capability transfers cleanly and enter there, rather than pursuing roles where sector-specific knowledge is the substance of the job.
Key Takeaways
- Some pharmaceutical functions are far more accessible than others.
- Finance, HR, IT, and operations transfer more readily than R&D or regulatory.
- Sector knowledge must be built deliberately once inside.
- Adjacent regulated industries transfer better than unregulated ones.
- Be realistic about which roles are genuinely reachable.
Where Entry Is Genuinely Possible
Pharmaceutical functions vary enormously in how much sector-specific knowledge they require. Finance, human resources, information technology, procurement, and general operations roles draw substantially on capabilities that transfer across industries, and companies hire externally into them regularly. Regulatory affairs, clinical development, pharmacovigilance, medical affairs, and research leadership require knowledge that takes years to build and is largely the substance of the role. Candidates who target the first group enter successfully; those who target the second usually do not, regardless of general excellence.
Regulated-Industry Experience Transfers Better
Candidates coming from other heavily regulated environments, medical devices, food safety, aviation, nuclear, financial services, bring an understanding of operating under regulatory constraint that is genuinely valued and materially easier to translate than experience from unregulated industries. The instinct that documentation matters, that changes have compliance consequences, and that regulators are a permanent stakeholder rather than an obstacle is difficult to teach and readily recognised. Emphasise this explicitly if it applies, since it addresses the main concern a pharmaceutical hiring manager has about an outside candidate.
Build Sector Knowledge Deliberately Once In
Entering through a transferable function is the beginning rather than the end. Progression into broader pharmaceutical leadership requires understanding how the industry actually works: development timelines and their drivers, regulatory pathways, how products are reimbursed, why patent positions matter, and the economics that follow from all of it. This will not accumulate passively from a functional role, so it must be pursued through curiosity, cross-functional involvement, and deliberate learning. Candidates who enter and remain functionally siloed rarely progress into general pharmaceutical leadership.
Be Honest About the Ceiling
Some destinations are unrealistic from outside. A career change into a CMO, CSO, or head of regulatory role is essentially not available without the underlying professional background, and pursuing it wastes time. Equally, general management of a pharmaceutical business is reachable but usually requires years inside the industry first. Being clear-eyed about which roles are genuinely available now, which become available after building sector knowledge, and which are effectively closed makes the transition far more efficient than pursuing everything simultaneously.
What This Looks Like in Practice
A candidate changing into pharmaceuticals targets functions where capability transfers, finance, HR, IT, procurement, operations, emphasises experience from other regulated environments explicitly, then builds sector knowledge deliberately through cross-functional involvement rather than remaining siloed, while being realistic about which destinations require an underlying professional background.
The Mistake Candidates Keep Making
The most common mistake is pursuing roles where sector-specific knowledge is the substance of the job, on the strength of general leadership excellence. A capable executive applying for regulatory or development leadership without the underlying background is not competitive against candidates for whom that knowledge is a career’s accumulation, and the repeated rejections are discouraging and avoidable.
Accessibility of Pharma Functions From Outside
| Function | Accessibility |
|---|---|
| Finance, HR, IT, procurement | Readily accessible |
| Manufacturing and supply chain | Accessible, especially from regulated industries |
| Commercial and market access | Moderately accessible with adaptation |
| Quality | Accessible from other regulated manufacturing |
| Regulatory, clinical, medical, research | Effectively requires the underlying background |
The Bottom Line
Career change into pharmaceuticals works when you target functions where capability genuinely transfers and emphasise experience from other regulated environments, then build sector knowledge deliberately from inside, rather than pursuing roles where the sector-specific knowledge is itself the substance of the job. Be deliberate about this, and you will be choosing between offers rather than hoping for one.
Related Reading
For more, see How to Move from Clinical Research to Executive Leadership, Building Your Network in the Pharmaceutical Industry, What Pharma Recruiters Wish Candidates Knew.
Frequently Asked Questions
- Q: Which pharma functions are accessible from other industries?
- A: Finance, HR, IT, procurement, general operations, and often manufacturing and quality, particularly for candidates from other regulated environments.
- Q: Which are effectively closed?
- A: Regulatory affairs, clinical development, pharmacovigilance, medical affairs, and research leadership, where the sector-specific knowledge is the substance of the role.
- Q: Does experience in another regulated industry help?
- A: Considerably; the instinct that documentation matters, changes carry compliance consequences, and regulators are permanent stakeholders is hard to teach and readily valued.
- Q: How do I progress after entering?
- A: By deliberately building understanding of development timelines, regulatory pathways, reimbursement, and patent economics through cross-functional involvement rather than remaining functionally siloed.
- Q: What is the common mistake?
- A: Pursuing roles where sector knowledge is the job itself on the strength of general leadership excellence, which is not competitive and produces avoidable rejection.
![](https://www.jrgpartners.com/wp-content/uploads/2025/12/tanya-gallardo.jpeg")
Tanya Gallardo
Managing Director, Executive Search & AI Talent Strategy
Tanya Gallardo is the Managing Director of Executive Search & AI Talent Strategy at JRG Partners, leading C-suite and Board engagements across key growth sectors including Technology, Financial Services, and Manufacturing.
With over 18 years of experience specializing in disruptive technology leadership, Tanya is recognized as a leading authority on talent architecture for future-focused executive roles, such as the Chief AI Officer (CAIO) and Chief Digital Officer (CDO). Her expertise lies in accurately assessing the cultural fit and technical depth required to ensure a high return on investment (ROI) for critical leadership appointments.
Prior to her role at JRG Partners, Tanya held senior roles directing global talent acquisition strategies at a major publicly-traded technology firm, advising on organizational design and succession planning for emerging executive functions. She is a recognized speaker and contributor to industry events, sharing data-driven insights on executive compensation, leadership development, and the measurable business impact of C-suite talent.
